help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abel, M. H.
Right arrow Articles by Baird, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abel, M. H.
Right arrow Articles by Baird, D. T.

Endocrinology, Vol 106, 1599-1606, Copyright © 1980 by Endocrine Society


ARTICLES

The effect of 17 beta-estradiol and progesterone on prostaglandin production by human endometrium maintained in organ culture

MH Abel and DT Baird

Endometrium collected from 18 normal women at various stages of the menstrual cycle was maintained in organ culture for periods of 6 days. Both prostaglandin F2 alpha (PGF2 alpha) and PGE were detected in medium from late proliferative (days 10-14; n = 13) and late secretory (days 20-26; n = 5) endometria cultured in the absence of exogenous steroids. During the first 48 h in culture, the output of PGF2 alpha by secretory endometrium was significantly greater than that of proliferative tissue. The addition of 17 beta-estradiol to the culture medium at doses ranging from 1.0-100.0 ng/ml induced a significant increase in the output of PGF2 alpha by secretory but not proliferative endometria. The addition of progesterone at doses ranging from 5.0- 500.0 ng/ml significantly reduced the output of PGF2 alpha and PGE by both proliferative and secretory endometria and prevented the 17 beta- estradiol-stimulated increase in PGF2 alpha output by secretory tissue.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
F. Modugno, R. B. Ness, C. Chen, and N. S. Weiss
Inflammation and Endometrial Cancer: A Hypothesis
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2840 - 2847.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Li, J.C. Felix, J. Hao, P. Minoo, and J.K. Jain
Menstrual-like breakdown and apoptosis in human endometrial explants
Hum. Reprod., June 1, 2005; 20(6): 1709 - 1719.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. J. Sales, S. A. Milne, A. R. W. Williams, R. A. Anderson, and H. N. Jabbour
Expression, Localization, and Signaling of Prostaglandin F2{alpha} Receptor in Human Endometrial Adenocarcinoma: Regulation of Proliferation by Activation of the Epidermal Growth Factor Receptor and Mitogen-Activated Protein Kinase Signaling Pathways
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 986 - 993.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. A. Milne and H. N. Jabbour
Prostaglandin (PG) F2{alpha} Receptor Expression and Signaling in Human Endometrium: Role of PGF2{alpha} in Epithelial Cell Proliferation
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1825 - 1832.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. K. Hapangama, H. O. D. Critchley, T. A. Henderson, and D. T. Baird
Mifepristone-Induced Vaginal Bleeding Is Associated with Increased Immunostaining for Cyclooxygenase-2 and Decrease in Prostaglandin Dehydrogenase in Luteal Phase Endometrium
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5229 - 5234.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
N. Sugino, A. Karube-Harada, S. Kashida, S. Takiguchi, and H. Kato
Reactive oxygen species stimulate prostaglandin F2{alpha} production in human endometrial stromal cells in vitro
Hum. Reprod., September 1, 2001; 16(9): 1797 - 1801.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. A. McCracken, E. E. Custer, and J. C. Lamsa
Luteolysis: A Neuroendocrine-Mediated Event
Physiol Rev, April 1, 1999; 79(2): 263 - 323.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. O. D. Critchley, R. L. Jones, R. G. Lea, T. A. Drudy, R. W. Kelly, A. R. W. Williams, and D. T. Baird
Role of Inflammatory Mediators in Human Endometrium during Progesterone Withdrawal and Early Pregnancy
J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 240 - 248.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
W. X. Wu, X. H. Ma, Q. Zhang, L. Buchwalder, and P. W. Nathanielsz
Regulation of Prostaglandin Endoperoxide H Synthase 1 and 2 by Estradiol and Progesterone in Nonpregnant Ovine Myometrium and Endometrium in Vivo
Endocrinology, September 1, 1997; 138(9): 4005 - 4012.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. D. Graham and C. L. Clarke
Physiological Action of Progesterone in Target Tissues
Endocr. Rev., August 1, 1997; 18(4): 502 - 519.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
C. J. Lockwood and F. Schatz
A Biological Model for the Regulation of Peri-Implantational Hemostasis and Menstruation
Reproductive Sciences, July 1, 1996; 3(4): 159 - 165.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society